These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7051724)

  • 1. Overview of progress in hematology in 1981 with special reference to leukocyte.
    Kimura K
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):1-10. PubMed ID: 7051724
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of new antileukemic agents].
    Yamada K; Ohno R
    Nihon Rinsho; 1981 Aug; 39(8):2815-20. PubMed ID: 7038206
    [No Abstract]   [Full Text] [Related]  

  • 3. [Symposium on treatment of cancer. 1. Chemotherapy of acute leukemia in adults].
    Yamada K
    Nihon Naika Gakkai Zasshi; 1984 Nov; 73(11):1585-9. PubMed ID: 6394671
    [No Abstract]   [Full Text] [Related]  

  • 4. Action mechanism of antileukemic agents with special reference to nucleic acid metabolism of leukemic cells.
    Nakamura T
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1203-18. PubMed ID: 6762793
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy of acute leukemia in adults.
    Yamada K
    Jpn J Med; 1985 Feb; 24(1):73-5. PubMed ID: 3858569
    [No Abstract]   [Full Text] [Related]  

  • 6. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy.
    Skipper HE; Perry S
    Cancer Res; 1970 Jun; 30(6):1883-97. PubMed ID: 4917694
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of aclarubicin and its metabolites in humans and their disposition in blood cells.
    Ando S; Nakamura T; Kagawa D; Ueda T; Nishimura T; Kubo A; Tsutani H; Sasada M; Uchino H
    Cancer Treat Rep; 1986 Jul; 70(7):835-41. PubMed ID: 3459574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthracyclines in the treatment of acute nonlymphocytic leukemias.
    Boiron M; Jacquillat C; Marty M; Weil M; Gisselbrecht C
    Cancer Treat Rep; 1981; 65 Suppl 4():73-6. PubMed ID: 6955013
    [No Abstract]   [Full Text] [Related]  

  • 10. DCMP therapy in acute leukemia--the experimental and clinical study.
    Ogawa M; Hoshino A
    Nihon Ketsueki Gakkai Zasshi; 1974 Jun; 37(3):344-50. PubMed ID: 4479924
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of acute leukemia].
    Barry A; Delage JM
    Union Med Can; 1970 Jun; 99(6):1045-54. PubMed ID: 5280031
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemical modification of anthracycline antibiotics. V. Synthesis of 2-hydroxyaclacinomycin A by chemical glycosidation.
    Tanaka H; Yoshioka T; Yoshimoto A; Shimauchi Y; Ishikura T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1983 May; 36(5):601-3. PubMed ID: 6874576
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy of mouse leukemia L1210 by 1-beta-D-arabinofuranosylcytosine and 6-[(4-nitrobenzyl)thio]-9-beta-D-ribofuranosylpurine.
    Cass CE; Muzik H; Paterson AR
    Cancer Res; 1975 May; 35(5):1187-93. PubMed ID: 1120308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of aclacinomycin in acute leukemia and lymphosarcoma.
    Mathé G; Gil MA; Delgado M; Bayssas M; Gouveia J; Ribaud P; Machover D; Misset JL; de Vassal F; Schwarzenberg L; Jasmin C; Hayat M
    Recent Results Cancer Res; 1980; 74():217-22. PubMed ID: 6893752
    [No Abstract]   [Full Text] [Related]  

  • 16. Aclarubicin: experimental and clinical experience.
    Röthig HJ; Kraemer HP; Sedlacek HH
    Drugs Exp Clin Res; 1985; 11(2):123-5. PubMed ID: 3915280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
    Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of acute non-lymphocytic leukemia in Saitama Cancer Center.
    Sampi K; Sakurai M; Kaneko Y; Hattori M
    Anticancer Res; 1985; 5(3):293-6. PubMed ID: 4015043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of acute leukemia: contribution of the new anthracyclinic drugs].
    Lambertenghi-Deliliers G; Colajori E; Annaloro C; Polli EE
    Recenti Prog Med; 1985; 76(7-8):392-7. PubMed ID: 3906794
    [No Abstract]   [Full Text] [Related]  

  • 20. A phase II study of aclacinomycin A in acute leukemia in adults.
    Yamada K; Nakamura T; Tsuruo T; Kitahara T; Maekawa T; Uzaka Y; Kurita S; Masaoka T; Takaku F; Hirota Y; Amaki I; Osamura S; Ito M; Nakano N; Oguro M; Inagaki J; Onozawa K
    Cancer Treat Rev; 1980 Dec; 7(4):177-82. PubMed ID: 6938305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.